GlassScriptPhysician profile
Joanne Allison Carter
NPI 1841061058
$257.37
in general payments reported to CMS, 2019-2025
10 companies · $86.40 in 2025
The $86.40 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $171 · 2025: $86.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $41.90 | 2024 | Cabometyx |
| Agios Pharmaceuticals, INC. | $35.67 | 2024 | |
| Genentech USA, INC. | $29.35 | 2024 | Lunsumio, Polivy, Columvi |
| Organon LLC | $28.00 | 2025 | Nexplanon |
| Astrazeneca Pharmaceuticals LP | $27.03 | 2024 | Calquence |
| Novartis Pharmaceuticals Corporation | $22.05 | 2025 | |
| Fennec Pharmaceuticals, INC. | $19.67 | 2025 | Fyarro |
| Geron Corporation | $19.37 | 2024 | Rytelo |
| Stemline Therapeutics INC. | $17.65 | 2024 | Orserdu |
| Exact Sciences Corporation | $16.68 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.